Search results

Page results

• UCLH recruits first patient globally for new Alzheimer’s Disease trial

  UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.

• Cancer immunotherapy treatment

  This page is for patients receiving steroids for immunotherapy toxicity.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• Secretary of State for Health and Social Care visits UCLH

  The Secretary of State for Health and Social Care Sajid Javid came to University College Hospital Grafton Way Building on Friday 4 February 2022.

• Anti bribery statement - our commitment

  At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.

• UCLH to lead data initiative to improve care for myeloma patients

  UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).

• New surgical technique preserves continence in men after prostate removal

  A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.

• Improving clinic attendance and reducing health inequalities in children and young people

  A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.

• Aftercare Guidance Following an Intrathecal Baclofen Pump Implant

  Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.